EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective Effect of Limosilactobacillus fermentum ME-3 against the Increase in Paracellular Permeability Induced by Chemotherapy or Inflammatory Conditions in Caco-2 Cell Models

Alex De Gregorio iD, Annalucia Serafino, Ewa Krystyna Krasnowska iD, Fabiana Superti iD, Maria Rosa Di Fazio, Maria Pia Fuggetta, Ivano Hammarberg Ferri, Carla Fiorentini iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alex De Gregorio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Pharmacology, National Research Council of Italy (CNR), Via Fosso del Cavaliere 100, 00133 Rome, Italy. Hauptthemen laut MEDLINE: Limosilactobacillus fermentum. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Essential Integratori S.r.l., Bologna, Italy, Institute of Translational Pharmacology, Association for Research on Integrative Oncology Therapies (ARTOI) Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy- or inflammation-induced increase in intestinal permeability represents a severe element in disease evolution in patients suffering from colorectal cancer and gut inflammatory conditions. Emerging data strongly support the gut microbiota’s role in preserving intestinal barrier integrity, whilst both chemotherapy and gut inflammation alter microbiota composition. Some probiotics might have a strong re-balancing effect on the gut microbiota, also positively affecting intestinal barrier integrity. In this study, we asked whether Limosilactobacillus fermentum ME-3 can prevent the intestinal paracellular permeability increase caused by the chemotherapeutic drug Irinotecan or by inflammatory stimuli, such as lipopolysaccharide (LPS). As an intestinal barrier model, we used a confluent and polarized Caco-2 cell monolayer and assessed the ME-3-induced effect on paracellular permeability by transepithelial electrical resistance (TEER) and fluorescent-dextran flux assays. The integrity of tight and adherens junctions was examined by confocal microscopy analysis. Transwell co-cultures of Caco-2 cells and U937-derived macrophages were used as models of LPS-induced intestinal inflammation to test the effect of ME-3 on release of the pro-inflammatory cytokines Tumor Necrosis Factor α, Interleukin-6, and Interleukin-8, was measured by ELISA. The results demonstrate that ME-3 prevents the IRI-induced increment in paracellular permeability, possibly by modulating the expression and localization of cell junction components. In addition, ME-3 inhibited both the increase in paracellular permeability and the release of pro-inflammatory cytokines in the co-culture model of LPS-induced inflammation. Our findings sustain the validity of L. fermentum ME-3 as a valuable therapeutic tool for preventing leaky gut syndrome, still currently without an available specific treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Limosilactobacillus fermentumHumansCaco-2 CellsLipopolysaccharidesInflammationPermeabilityIntestinal MucosaTight Junctions

Stichwörter der Autor:innen

Limosilactobacillus fermentum ME-3®chemotherapycolon cancerdysbiosismembrane permeabilitytight junctions

Substanzen

Lipopolysaccharides

Autor:innen und Institutionen

  • Institute of Translational Pharmacology, National Research Council of Italy (CNR), Via Fosso del Cavaliere 100, 00133 Rome, Italy.
  • National Centre for Innovative Technologies in Public Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy.
  • Association for Research on Integrative Oncology Therapies (ARTOI) Foundation, Via Ludovico Micara, 73, 00165 Rome, Italy.
  • SH Outpatient Oncology Clinic, Via dei Paceri 86/A, 47891 Falciano, San Marino.
  • (IHF) Outpatient Oncology Clinic, Via dell'Indipendenza 20, 40121 Bologna, Italy.

ORCID-Profile: Alex De Gregorio, Ewa Krystyna Krasnowska, Fabiana Superti, Carla Fiorentini

Förderung

  • Essential Integratori S.r.l., Bologna, Italy
  • Institute of Translational Pharmacology
  • Association for Research on Integrative Oncology Therapies (ARTOI) Foundation

Zitieren

APA

De Gregorio, A., Serafino, A., Krasnowska, E. K., Superti, F., Di Fazio, M. R., Fuggetta, M. P., Hammarberg Ferri, I., & Fiorentini, C. (2023). Protective Effect of Limosilactobacillus fermentum ME-3 against the Increase in Paracellular Permeability Induced by Chemotherapy or Inflammatory Conditions in Caco-2 Cell Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076225

Vancouver

De Gregorio A, Serafino A, Krasnowska EK, Superti F, Di Fazio MR, Fuggetta MP, et al. Protective Effect of Limosilactobacillus fermentum ME-3 against the Increase in Paracellular Permeability Induced by Chemotherapy or Inflammatory Conditions in Caco-2 Cell Models. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076225

BibTeX
@article{DeGregorio2023,
  author = {De Gregorio, Alex and Serafino, Annalucia and Krasnowska, Ewa Krystyna and Superti, Fabiana and Di Fazio, Maria Rosa and Fuggetta, Maria Pia and Hammarberg Ferri, Ivano and Fiorentini, Carla},
  title = {Protective Effect of Limosilactobacillus fermentum ME-3 against the Increase in Paracellular Permeability Induced by Chemotherapy or Inflammatory Conditions in Caco-2 Cell Models},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076225}
}
Kostenlos starten →